These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Is cystic fibrosis mucus abnormal? King M Pediatr Res; 1981 Feb; 15(2):120-2. PubMed ID: 7254936 [TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of short-term administration of aerosolised recombinant human DNase I in adults with stable stage cystic fibrosis. Ranasinha C; Assoufi B; Shak S; Christiansen D; Fuchs H; Empey D; Geddes D; Hodson M Lancet; 1993 Jul; 342(8865):199-202. PubMed ID: 8100928 [TBL] [Abstract][Full Text] [Related]
28. Compaction assay: a rapid and simple in vitro method to assess the responsiveness of a biopolymer matrix to enzymatic modification. Daugherty AL; Patapoff TW; Clark RC; Sinicropi DV; Mrsny RJ Biomaterials; 1995 May; 16(7):553-8. PubMed ID: 7492720 [TBL] [Abstract][Full Text] [Related]
29. Medium term treatment of stable stage cystic fibrosis with recombinant human DNase I. Shah PL; Scott SF; Fuchs HJ; Geddes DM; Hodson ME Thorax; 1995 Apr; 50(4):333-8. PubMed ID: 7785003 [TBL] [Abstract][Full Text] [Related]
30. New treatment strategies in cystic fibrosis: rhDNase. Shah PL; Hodson ME Monaldi Arch Chest Dis; 1996 Apr; 51(2):125-9. PubMed ID: 8680379 [TBL] [Abstract][Full Text] [Related]
31. Retrospective review of the effects of rhDNase in children with cystic fibrosis. Davies J; Trindade MT; Wallis C; Rosenthal M; Crawford O; Bush A Pediatr Pulmonol; 1997 Apr; 23(4):243-8. PubMed ID: 9141109 [TBL] [Abstract][Full Text] [Related]
32. Recombinant human DNase in management of lobar atelectasis due to retained secretions. Touleimat BA; Conoscenti CS; Fine JM Thorax; 1995 Dec; 50(12):1319-21; discussion 1323. PubMed ID: 8553310 [TBL] [Abstract][Full Text] [Related]
38. Effects of rhDNase on purulent airway secretions in chronic bronchitis. Puchelle E; Zahm JM; de Bentzmann S; Grosskopf C; Shak S; Mougel D; Polu JM Eur Respir J; 1996 Apr; 9(4):765-9. PubMed ID: 8726943 [TBL] [Abstract][Full Text] [Related]
39. DNA concentration and length in sputum of patients with cystic fibrosis during inhalation with recombinant human DNase. Brandt T; Breitenstein S; von der Hardt H; Tümmler B Thorax; 1995 Aug; 50(8):880-2. PubMed ID: 7570441 [TBL] [Abstract][Full Text] [Related]
40. The role of mucous glycoproteins in the rheologic properties of cystic fibrosis sputum. Lethem MI; James SL; Marriott C Am Rev Respir Dis; 1990 Nov; 142(5):1053-8. PubMed ID: 2240828 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]